Yesintek, formerly known as Bmab 1200, is a human interleukin-12 and -23 antagonist. The FDA has approved Yesintek (Ustekinumab-kfce), a biosimilar to Stelara (Ustekinumab), for the treatment of ...
Sixty waterborne disease outbreaks associated with splash pads were reported during 1997 to 2022, according to research published in the Dec. 5 issue of the U.S ...
The overall incidence of cutaneous melanoma was 1.74 per 1 million person-years in pediatric patients and 62.1 per 1 million person-years in adolescents and young adults. The incidence of cutaneous ...
From 2016 to 2021, there was a decrease in cervical cancer deaths among U.S. women aged younger than 25 years, according to a research letter published online N ...